CJC-1295 (no DAC) + Ipamorelin is a peptide combination that has become a major focus in modern growth hormone and endocrine research. Scientists study this pairing for its ability to stimulate the natural release of growth hormone by acting on growth hormone–releasing hormone (GHRH) and ghrelin receptor pathways within the body.

Because of its interaction with these pathways, CJC-1295 (no DAC) + Ipamorelin has generated strong interest in research surrounding growth hormone pulsatility, recovery processes, and metabolic function. Researchers continue to explore how this combination may influence growth hormone activity and support pathways associated with body composition and overall metabolic efficiency.

At Titan Labs, our CJC-1295 (no DAC) + Ipamorelin (5mg/5mg) research compound is prepared for laboratory and scientific study, allowing researchers to investigate its role in growth hormone signaling, endocrine pathways, and body composition research.

For research purposes only. Not for human consumption.